Idera To Present At The Stifel 2016 Healthcare Conference

CAMBRIDGE, Mass. and EXTON, Pa., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, today announced that Idera's Chief Executive Officer, Vincent Milano will provide a corporate overview the Stifel 2016 Healthcare Conference on Wednesday November 16, 2016 at 3:00 p.m. Eastern Time at the Lotte New York Palace Hotel.

Live audio webcast of Idera's presentations will be accessible in the Investors and Media section of Idera's website at http://www.iderapharma.com. Archived versions will also be available on the Company's website after the event for 90 days. 

About Idera Pharmaceuticals Idera Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel nucleic acid-based therapies for the treatment of certain cancers and rare diseases. Idera's proprietary technology involves designing synthetic oligonucleotide-based drug candidates to modulate the activity of specific TLRs. In addition to its TLR programs, Idera has used its proprietary knowledge to create a third generation antisense technology platform which inhibits the production of disease-associated proteins by targeting RNA. To learn more about Idera, visit www.iderapharma.com.

Investor and Media ContactRobert DoodyVP, IR & Corporate Communications617-679-5515 (office)484-639-7235 (mobile)rdoody@iderapharma.com

Primary Logo

If you liked this article you might like

Why 2018 Will Be Better for Biotech Deals Than 2017

Why 2018 Will Be Better for Biotech Deals Than 2017

Achillion Shares Are Plunging on Termination of Hepatitis C Pact

Achillion Shares Are Plunging on Termination of Hepatitis C Pact

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

8 Biotech Stocks Under $10 Making Big Moves Higher

8 Biotech Stocks Under $10 Making Big Moves Higher

5 Stocks Ready for Breakouts

5 Stocks Ready for Breakouts